Yael Shachor-Meyouhas

7PUBLICATIONS
18CO-AUTHORS
Plant and fungus systematics and taxonomyPredictive and prognostic markersNanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)Infectious diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 27, 2025
Risk Factors for Severe Outcomes Among Pediatric Cancer Patients with Respiratory Viral Infection.

Alon Kristal, Avi Magid, Nira Arad-Cohen

|Aug 27, 2024
Knowledge of the Serological Response to the Third BNT162b2 Vaccination May Influence Compliance of Healthcare Workers to Booster Dose.

Avi Magid, Khetam Hussein, Halima Dabaja-Younis

|Apr 10, 2023
Revaccination of children with acute lymphoblastic leukemia following completion of chemotherapy.

Adi Anafy, Gil Gilad, Nadav Michaan

|Feb 28, 2023
Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers.

Yael Shachor-Meyouhas, Halima Dabaja-Younis, Avi Magid

|Oct 27, 2022
Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers.

Khetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen

Pageof 2